Baseline in vitro efficacy of ACT component drugs on Plasmodium falciparum clinical isolates from Mali.
about
Identification of a mutant PfCRT-mediated chloroquine tolerance phenotype in Plasmodium falciparumUse of the atmospheric generators for capnophilic bacteria Genbag-CO2 for the evaluation of in vitro Plasmodium falciparum susceptibility to standard anti-malarial drugs.Ex vivo susceptibility of Plasmodium falciparum isolates from Dakar, Senegal, to seven standard anti-malarial drugsImpact of antimalarial treatment and chemoprevention on the drug sensitivity of malaria parasites isolated from ugandan children.Repeated artemisinin-based combination therapies in a malaria hyperendemic area of Mali: efficacy, safety, and public health impactPlasmodium falciparum clearance rates in response to artesunate in Malian children with malaria: effect of acquired immunity.Role of known molecular markers of resistance in the antimalarial potency of piperaquine and dihydroartemisinin in vitro.Monitoring antimalarial drug efficacy: current challenges.Reduced ex vivo susceptibility of Plasmodium falciparum after oral artemether-lumefantrine treatment in Mali.In vitro evaluations of antimalarial drugs and their relevance to clinical outcomes.Reliability of antimalarial sensitivity tests depends on drug mechanisms of action.In vitro activities of piperaquine, lumefantrine, and dihydroartemisinin in Kenyan Plasmodium falciparum isolates and polymorphisms in pfcrt and pfmdr1.
P2860
Q28473923-136FCB03-FDEB-401B-BFC3-C4866FC33CCBQ34541163-E08AEFC1-E594-4572-BF08-443E26BA779AQ35533577-D75336E8-9E9E-4AB4-8FBE-F1505E227467Q35607844-713889E5-01F0-475E-9634-2C539FEFD7C4Q36080127-A28AADD0-4D6A-4FE3-9F71-6C0AFFFA0B29Q36796548-DC10142D-3920-43D3-8AC8-05D32084694FQ37144854-B3133100-03BD-4BEA-ACA0-E7E32C8129EFQ37225083-6AA12E26-B251-45FA-96F3-8FB2A9535FCCQ37621092-5534A444-DCF8-4827-8201-B605A7FA0200Q39224800-A6A70304-698D-4FCF-B7DA-C6F2EE3C2873Q40344256-9063FB8C-EA8D-41CA-AB52-311BE48885C8Q41937598-EE9EA9B8-A0BD-4A7D-9C8B-067D705952A2
P2860
Baseline in vitro efficacy of ACT component drugs on Plasmodium falciparum clinical isolates from Mali.
description
2008 nî lūn-bûn
@nan
2008年の論文
@ja
2008年論文
@yue
2008年論文
@zh-hant
2008年論文
@zh-hk
2008年論文
@zh-mo
2008年論文
@zh-tw
2008年论文
@wuu
2008年论文
@zh
2008年论文
@zh-cn
name
Baseline in vitro efficacy of ...... m clinical isolates from Mali.
@en
type
label
Baseline in vitro efficacy of ...... m clinical isolates from Mali.
@en
prefLabel
Baseline in vitro efficacy of ...... m clinical isolates from Mali.
@en
P2093
P50
P1476
Baseline in vitro efficacy of ...... m clinical isolates from Mali.
@en
P2093
Bakary Sidibe
Cheick P O Sangaré
Halima Kaddouri
Oumar Yattara
Véronique Hubert
P304
P356
10.1016/J.IJPARA.2007.12.002
P50
P577
2008-01-03T00:00:00Z